The Management of Spontaneous Pneumothorax: Clinical Review in 451 Cases.
- Author:
Tae Yun OH
1
;
Un Ha JANG
;
Sang Il BAE
Author Information
1. Department of Thoracic & Cardiovascular Surgery, Kangbuk Samsung Hospital, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
pneumothorax
- MeSH:
Chest Tubes;
Drainage;
Female;
Humans;
Male;
Oxygen;
Pneumothorax*;
Pulmonary Disease, Chronic Obstructive;
Recurrence;
Retrospective Studies;
Surgical Procedures, Operative;
Thoracic Surgery, Video-Assisted;
Thoracoscopy;
Thoracostomy;
Thoracotomy;
Tuberculosis, Pulmonary
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
1998;31(4):374-379
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
From March 1985 to June 1997, 451 patients of spontaneous pneumothorax treated at Kangbuk Samsung Hospital were reviewed retrospectively. Most of the patients were male (male to female ratio, 8.2:1). The mean age of the primary spontaneous pneumothorax (PSP) was 26.8 years, and that of secondary spontaneous pneumothorax (SSP) was 53.1 years. 330 out of 451 patients (73%) were PSP. The causes of the SSP were mostly pulmonary tuberculosis and COPD: 87 patients (72%), and 24 patients (19.2%), respectively. All the patient were treated by one of the following modalities: 1)rest and oxygen therapy in 42 patients, 2) closed thoracostomy in 208 patients, 3) thoracotomy in 156 patients, 4) VATS bullectomy in 45 patients. The mean duration of postoperative chest tube drainage was as following: thoracotomy 8.3 days, VATS bullectomy 4.7 days. For recent 3 consecutive years, VATS bullectomy has become the more frequently applied operative procedure than thoracotomy in the treatment of surgically indicated PSP, from 33% in 1994 to 78% in 1996. With the minimally invasive thoracoscopic surgery being more prevalent, VATS bullectomy will be able to be the 1st choice of treatment not only for the recurrent pneumothoracies but also for the some selected cases of the 1st episode pneumothoracies. To verify this approach as clinically acceptable one in terms of cost-effectiveness, recurrence rate, etc, a large scale of multi-institutional clinical study will be needed in a sooner time.
